MAI Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-150
Closed -$4.83K 4618
2026
Q1
$4.83K Buy
150
+87
+138% +$3.22K ﹤0.01% 3530
2025
Q4
$2.65K Sell
63
-30
-32% -$1.21K ﹤0.01% 3345
2025
Q3
$3.19K Hold
93
﹤0.01% 3179
2025
Q2
$2.51K Sell
93
-4
-4% -$116 ﹤0.01% 3334
2025
Q1
$2.88K Sell
97
-28
-22% -$1.07K ﹤0.01% 2885
2024
Q4
$4.95K Buy
+125
New +$4.73K ﹤0.01% 2771

Other funds holding VCYT

MAI Capital Management's VCYT Position: Q2 2026 in Review

MAI Capital Management sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 150 shares — an estimated $4.83K sold.

MAI Capital Management first reported a position in VCYT in Q4 2024 and held it in 6 quarters. The position peaked at $4.95K in Q4 2024. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • MAI Capital Management reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 150 Veracyte shares in Q2 2026, an estimated $4.83K.
  • MAI Capital Management first reported a position in Veracyte in Q4 2024 and held it in 6 quarters.
  • MAI Capital Management's Veracyte position peaked at $4.95K in Q4 2024.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.